Vir Biotechnology (VIR) has been in focus after its experimental two drug regimen for chronic hepatitis delta met all goals ...

Vir Biotechnology (VIR) stock rose 13% to $13.85 after Phase 3 ECLIPSE 1 hepatitis delta results. See the trial data, safety ...

Elebsiran is an investigational hepatitis B virus-targeting small interfering ribonucleic acid (siRNA) licensed from Alnylam ...

Biotechnology is a broad discipline in which biological processes, organisms, cells or cellular components are exploited to develop new technologies. New tools and products developed by ...

Many bioentrepreneurs incorrectly estimate the value of their technology by failing to account adequately for the cost, risk, ...

Dublin, Nov. 09, 2026 (GLOBE NEWSWIRE) -- "Global Biotechnology Market - Therapeutic Innovations & Forecast 2026-2034" has been added to ResearchAndMarkets.com's offering. The global biotechnology ...

In this column, the author discusses how food biotechnology is evolving from scientific innovation into a scalable manufacturing platform capable of reshaping the future of food production through ...

Designed to provide broad exposure to the Health Care ETFs category of the market, the iShares Biotechnology ETF (IBB) is a smart beta exchange traded fund launched on 02/05/2001. What Are Smart Beta ...

Ended quarter with approximately $901 million in cash, cash equivalents and investments, excluding $90 million in upfront ...

The National Security Commission on Emerging Biotechnology visited UW–Madison to discuss Wisconsin’s biohealth strengths, ...

Researchers propose the Applied and Conservation Mycology Framework to align fungal biotechnology with Indigenous Knowledge ...